To study gains in enhancer features within the SOX2 locus, we initially focused our analyses on luminal A breast cancer, the most common subtype of BRCA to significantly (P = 0.021, Tukey's test) overexpress SOX2 (Supplementary Figure S1C) (90,117). This evidence concerns the gene SOX2 and breast carcinoma.